Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012)
Supernus Pharmaceuticals (SUPN) posted quarterly Preferred Shares of $49000.0 for Q1 2012, little changed on a QoQ basis from $49000.0 in Q4 2011.
Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012) Analysis & Trends
Supernus Pharmaceuticals has reported Preferred Shares for 2 years, with the latest figure at $49000.0 in Q1 2012.
- Preferred Shares for Q1 2012 came in at $49000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2012 was $49000.0 (changed N/A YoY), and the FY2011 annual result was $49000.0, changed N/A from the prior year.
- Preferred Shares was little changed at $49000.0 in Q1 2012, from $49000.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $49000.0 in Q4 2011 and troughed at $49000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 49,000.00 |
| Dec 31, 2011 | 49,000.00 |